Key result
Novel r'-wave algorithm predicts Brugada syndrome after flecainide testing with ~0.92 AUC.
Why the study?
Several ECG criteria have been evaluated as predictors of a positive sodium channel blocker provocation test for Brugada syndrome, prompting this study to test all previously proposed criteria in a large cohort and evaluate a new r’-wave algorithm.
Cohort (n=395)
No
Answers are grounded in this paper and cite their sources.
May support ECG prediction of Brugada syndrome; hypothesis-generating and requires prospective validation before clinical adoption.
A diagnosis of Brugada syndrome (BrS) is based on the presence of a type 1 electrocardiogram (ECG) pattern, either spontaneously or after a Sodium Channel Blocker Provocation Test (SCBPT). Several ECG criteria have been evaluated as predictors of a positive SCBPT, such as the β-angle, the α-angle, the duration of the base of the triangle at 5 mm from the r’-wave (DBT- 5 mm), the duration of the base of the triangle at the isoelectric line (DBT- iso), and the triangle base/height ratio. The aim of our study was to test all previously proposed ECG criteria in a large cohort study and to evaluate an r’-wave algorithm for predicting a BrS diagnosis after an SCBPT. We enrolled all patients who consecutively underwent SCBPT using flecainide from January 2010 to December 2015 in the test cohort and from January 2016 to December 2021 in the validation cohort. We included the ECG criteria with the best diagnostic accuracy in relation to the test cohort in the development of the r’-wave algorithm (β-angle, α-angle, DBT- 5 mm, and DBT- iso.) Of the total of 395 patients enrolled, 72.4% were male and the average age was 44.7 ± 13.5 years. Following the SCBPTs, 24.1% of patients (n = 95) were positive and 75.9% (n = 300) were negative. ROC analysis of the validation cohort showed that the AUC of the r’-wave algorithm (AUC: 0.92; CI 0.85–0.99) was significantly better than the AUC of the β-angle (AUC: 0.82; 95% CI 0.71–0.92), the α-angle (AUC: 0.77; 95% CI 0.66–0.90), the DBT- 5 mm (AUC: 0.75; 95% CI 0.64–0.87), the DBT- iso (AUC: 0.79; 95% CI 0.67–0.91), and the triangle base/height (AUC: 0.61; 95% CI 0.48–0.75) (p < 0.001), making it the best predictor of a BrS diagnosis after an SCBPT. The r’-wave algorithm with a cut-off value of ≥2 showed a sensitivity of 90% and a specificity of 83%. In our study, the r’-wave algorithm was proved to have the best diagnostic accuracy, compared with single electrocardiographic criteria, in predicting the diagnosis of BrS after provocative testing with flecainide.
No takes yet. Share an insight, caveat, or question.
Vetta et al. (2023) conducted a cohort in Brugada syndrome (n=395). r'-wave algorithm vs. Single ECG criteria (β-angle, α-angle, DBT-5 mm, DBT-iso, triangle base/height ratio) was evaluated on Diagnostic accuracy (AUC in validation cohort) for predicting a Brugada syndrome diagnosis after a Sodium Channel Blocker Provocation Test (AUC 0.92, 95% CI 0.85-0.99, p=<0.001). The r'-wave algorithm achieved an AUC of 0.92 with 90% sensitivity and 83% specificity for predicting Brugada syndrome after flecainide testing.
Synapse has enriched 10 related papers. Consider them for comparative context: